ZTS | tickerfilter.com

Fundamental analysis

70%

Profitability 68%

Dept financing 50%

Liquidity 48%

Performance 84%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

2.32%

1 Month

-7.00%

3 Months

-11.30%

6 Months

-16.03%

1 Year

-3.90%

2 Year

-11.77%

Key data

Stock price

$153.47

P/E Ratio

29.48

DAY RANGE

$150.50 - $153.92

EPS

$4.49

52 WEEK RANGE

$139.70 - $200.33

52 WEEK CHANGE

-$3.90

MARKET CAP

73.287 B

YIELD

1.06%

SHARES OUTSTANDING

453.051 M

DIVIDEND

$0.50

EX-DIVIDEND DATE

04-21-2025

NEXT EARNINGS DATE

05-06-2025

BETA

0.19

PUBLIC FLOAT

AVERAGE 10 VOLUME

$2,918,658

AVERAGE 30 VOLUME

$3,061,743

Company detail

CEO: Kristin C. Peck
Region: US
Website: zoetis.com
Employees: 13,800
IPO year: 2013

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts.

ZTS - Zoetis Inc.